Muss HB - Search Results

1

Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: cisplatin followed by radiation therapy--a pilot study of the Gynecologic Oncology Group.

Muss HB, Jobson VW, Homesley HD, Welander C, Ferree C. Muss HB, et al. Gynecol Oncol. 1987 Jan;26(1):35-40. doi: 10.1016/0090-8258(87)90069-2. Gynecol Oncol. 1987. PMID: 3792934

2

Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinoma.

Homesley HD, Scarantino CW, Muss HB, Welander CE. Homesley HD, et al. Among authors: muss hb. Gynecol Oncol. 1989 Aug;34(2):170-4. doi: 10.1016/0090-8258(89)90135-2. Gynecol Oncol. 1989. PMID: 2502486 Clinical Trial.

3

Vincristine infusion in refractory gynecologic malignancies.

Jackson DV Jr, Jobson VW, Homesley HD, Welander C, Hire EA, Pavy MD, Votaw ML, Richards F 2nd, Muss HB. Jackson DV Jr, et al. Among authors: muss hb. Gynecol Oncol. 1986 Oct;25(2):212-6. doi: 10.1016/0090-8258(86)90101-0. Gynecol Oncol. 1986. PMID: 3758831

4

Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.

Jobson VW, Muss HB, Thigpen JT, Homesley HD, Bundy B. Jobson VW, et al. Among authors: muss hb. Am J Clin Oncol. 1984 Aug;7(4):341-5. Am J Clin Oncol. 1984. PMID: 6540048

5

Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (a phase II trial of the gynecologic oncology group).

Muss HB, Bundy BN, Homesley HD, Wilbanks G. Muss HB, et al. Invest New Drugs. 1987;5(2):199-202. doi: 10.1007/BF00203546. Invest New Drugs. 1987. PMID: 3654152

6

Cisplatin-associated cortical blindness.

Pippitt CH Jr, Muss HB, Homesley HD, Jobson VW. Pippitt CH Jr, et al. Among authors: muss hb. Gynecol Oncol. 1981 Oct;12(2 Pt 1):253-5. doi: 10.1016/0090-8258(81)90155-4. Gynecol Oncol. 1981. PMID: 7197656 No abstract available.

7

Dosage range study of morphine sulfate controlled-release.

Homesley HD, Welander CE, Muss HB, Richards F. Homesley HD, et al. Among authors: muss hb. Am J Clin Oncol. 1986 Oct;9(5):449-53. doi: 10.1097/00000421-198610000-00018. Am J Clin Oncol. 1986. PMID: 2430448

8

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group).

Muss HB, Bundy B, DiSaia PJ, Homesley HD, Fowler WC Jr, Creasman W, Yordan E. Muss HB, et al. Cancer. 1985 Apr 15;55(8):1648-53. doi: 10.1002/1097-0142(19850415)55:8<1648::aid-cncr2820550806>3.0.co;2-7. Cancer. 1985. PMID: 3884128 Clinical Trial.

9

Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.

Muss HB, Capizzi RL, Atkins JN, Powell BL, Cooper MR, Ferree D, McMahan RA, Jobson V, Craig J, Homesley HD, et al. Muss HB, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):166-70. Semin Oncol. 1985. PMID: 4040264 No abstract available.

10

Chemotherapy of advanced ovarian epithelial carcinoma with melphalan and levamisole: a pilot study of the Gynecologic Oncology Group.

Gusdon JP Jr, Homesley HD, Muss HB, Heise ER, Herbst GA, Richards F 2nd, Spurr CL, Lovelace JV, Di Saia PJ. Gusdon JP Jr, et al. Among authors: muss hb. Am J Obstet Gynecol. 1981 Sep 1;141(1):65-70. doi: 10.1016/0002-9378(81)90676-1. Am J Obstet Gynecol. 1981. PMID: 6973929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters